The biology of the P-glycoproteins.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed.

1. Top Common Differentially Expressed Genes in the Epileptogenic Nucleus of Two Strains of Rodents Susceptible to Audiogenic Seizures: WAR and GASH/Sal.Frontiers in neurology · 2020
   Article
2. Pharmacogenomics and personalized medicine · 2017
   Review
3. Relationship between therapeutic efficacy of arterial infusion chemotherapy and expression of P-glycoprotein and p53 protein in advanced hepatocellular carcinoma.World journal of gastroenterology · 2006
   Article
4. The mdr1a-/- mouse model of spontaneous colitis: a relevant and appropriate animal model to study inflammatory bowel disease.Immunologic research · 2005
   Review
5. The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane.Proceedings of the National Academy of Sciences of the United States of America · 2002
   Article
6. Detection of MDR1 single nucleotide polymorphisms C3435T and G2677T using real-time polymerase chain reaction: MDR1 single nucleotide polymorphism genotyping assay.AAPS pharmSci · 2002
   Article
7. In vitro intestinal permeability of factor Xa inhibitors: influence of chemical structure on passive transport and susceptibility to efflux.Pharmaceutical research · 2001
   Article
8. Morphine antinociception is enhanced in mdr1a gene-deficient mice.Pharmaceutical research · 2000
   Article
9. Molecular analysis of the multidrug transporter, P-glycoprotein.Cytotechnology · 1998
   Article
10. Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein.Proceedings of the National Academy of Sciences of the United States of America · 1998
    Article
11. Linear and cyclic peptides as substrates and modulators of P-glycoprotein: peptide binding and effects on drug transport and accumulation.The Biochemical journal · 1998
    Article
12. A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels.Proceedings of the National Academy of Sciences of the United States of America · 1998
    Article
13. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.Clinical pharmacokinetics · 1997
    Review
14. Proton-dependent multidrug efflux systems.Microbiological reviews · 1996
    Review
15. Release of noradrenaline from isolated rat tail artery induced by bafilomycin A1.Naunyn-Schmiedeberg's archives of pharmacology · 1996
    Article
16. Hepatic glutathione and glutathione S-conjugate transport mechanisms.The Yale journal of biology and medicine
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as